Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes

被引:8
|
作者
Wawina-Bokalanga, Tony [1 ]
Vanmechelen, Bert [1 ]
Lhermitte, Valentine [1 ]
Marti-Carreras, Joan [1 ]
Vergote, Valentijn [1 ]
Koundouno, Fara Raymond [2 ]
Akoi-Bore, Joseph [3 ]
Thom, Ruth [4 ]
Tipton, Tom [4 ]
Steeds, Kimberley [4 ]
Moussa, Keita Balla [5 ]
Amento, Ablam [5 ]
Laenen, Lies [1 ]
Duraffour, Sophie [6 ,7 ]
Gabriel, Martin [6 ,7 ]
Ruibal, Paula [7 ]
Hall, Yper [4 ]
Kader-Kond, Mandy [5 ]
Gunther, Stephan [7 ]
Baele, Guy [1 ]
Munoz-Fontela, Cesar [7 ]
Van Weyenbergh, Johan [1 ]
Carroll, Miles W. [4 ]
Maes, Piet [1 ]
机构
[1] Katholieke Univ Leuven, Leuven, Belgium
[2] Univ Julius Nyerere Kankan, Conakry, Guinea
[3] Inst Natl SantS Publ, Conakry, Guinea
[4] Publ Hlth England, Salisbury, Wilts, England
[5] Ctr Excellence Format & Rech Malad Prioritaires G, Conakry, Guinea
[6] German Ctr Infect Res, Hamburg, Germany
[7] Bernhard Nocht Inst Trop Med, Hamburg, Germany
基金
欧盟地平线“2020”; 欧洲研究理事会;
关键词
HEMORRHAGIC-FEVER; STOPPING RULES; NK CELLS; KIR; SELECTION; HLA; POLYMORPHISMS; PATHOGENESIS;
D O I
10.3201/eid2701.202177
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the genetic profiles of killer cell immunoglobulin-like receptors (KIRs) in Ebola virus-infected patients. We studied the relationship between KIR-human leukocyte antigen (HLA) combinations and the clinical outcomes of patients with Ebola virus disease (EVD). We genotyped KIRs and HLA class I alleles using DNA from uninfected controls, EVD survivors, and persons who died of EVD. The activating 2DS4-003 and inhibitory 2DL5 genes were significantly more common among persons who died of EVD; 2DL2 was more common among survivors. We used logistic regression analysis and Bayesian modeling to identify 2DL2, 2DL5, 2DS4-003, HLA-B-Bw4-Thr, and HLA-B-Bw4-Ile as probably having a significant relationship with disease outcome. Our findings highlight the importance of innate immune response against Ebola virus and show the association between KIRs and the clinical outcome of EVD.
引用
收藏
页码:76 / 84
页数:9
相关论文
共 50 条
  • [31] Killer Cell Immunoglobulin-Like Receptor Genotype and Killer Cell Immunoglobulin-Like Receptor-Human Leukocyte Antigen C Ligand Compatibility Affect the Severity of Hepatitis C Virus Recurrence After Liver Transplantation
    de Arias, Alejandro Espadas
    Haworth, Simone Elizabeth
    Belli, Luca Saverio
    Burra, Patrizia
    Pinzello, Giovambattista
    Vangeli, Marcello
    Minola, Ernesto
    Guido, Maria
    Boccagni, Patrizia
    De Feo, Tullia Maria
    Torelli, Rosanna
    Cardillo, Massimo
    Scalamogna, Mario
    Poli, Francesca
    LIVER TRANSPLANTATION, 2009, 15 (04) : 390 - 399
  • [32] Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos
    Daniela Garrido-Rodríguez
    Santiago Ávila-Ríos
    Claudia García-Morales
    Humberto Valenzuela-Ponce
    Christopher Ormsby
    Helena Reyes-Gopar
    Juan Carlos Fernandez-Lopez
    Gustavo Reyes-Terán
    Immunogenetics, 2016, 68 : 703 - 717
  • [33] Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes
    Guinan, K. J.
    Cunningham, R. T.
    Meenagh, A.
    Gonzalez, A.
    Dring, M. M.
    McGuinness, B. W.
    Middleton, D.
    Gardiner, C. M.
    GENES AND IMMUNITY, 2010, 11 (06) : 467 - 478
  • [34] Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis
    Wilson, Timothy J.
    Jobim, Mariana
    Jobim, Luiz Fernando
    Portela, Pamela
    Salim, Patricia H.
    Rosito, Mario A.
    Damin, Daniel C.
    Flores, Cristina
    Peres, Alessandra
    Machado, Marta Brenner
    Bogo Chies, Jose Artur
    Schwartsmann, Gilberto
    Roesler, Rafael
    HUMAN IMMUNOLOGY, 2010, 71 (03) : 293 - 297
  • [35] Human leukocyte antigen-C and killer immunoglobulin-like re-ceptors in reproductive medicine
    Rodriguez de Frias, Edgard
    Fernandez-Arquero, Miguel
    Subhi-Issa, Nabil
    Del Olmo, Ainhoa
    Cristobal, Ignacio
    Angel Herraiz, Miguel
    Sanchez-Ramon, Silvia
    MEDWAVE, 2021, 21 (10):
  • [36] Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children
    Singh, Kumud K.
    Qin, Min
    Brummel, Sean S.
    Angelidou, Konstantia
    Trout, Rodney N.
    Fenton, Terence
    Spector, Stephen A.
    PLOS ONE, 2016, 11 (03):
  • [37] Human leukocyte antigen-C and killer cell immunoglobulin-like receptor gene polymorphisms among patients with syphilis in a Chinese Han population
    Zhuang, Yun-Long
    Ren, Gui-Jie
    Tian, Ke-Li
    Li, Xin-Ye
    Zhu, Yong-Bao
    Liu, Jin-Ling
    Si, Gui-Ling
    Li, Peng
    Zhang, Yi
    Wang, Li
    Zhang, Wen-Jing
    Wang, Da-Jian
    Zhu, Chuan-Fu
    APMIS, 2012, 120 (10) : 828 - 835
  • [38] Killer-cell immunoglobulin-like receptor/human leukocyte antigen-C combination and 'great obstetrical syndromes' (Review)
    Yang, Xiuhua
    Meng, Tao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [39] Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis
    Littera, Roberto
    Chessa, Luchino
    Onali, Simona
    Figorilli, Francesco
    Lai, Sara
    Secci, Luca
    La Nasa, Giorgio
    Caocci, Giovanni
    Arras, Marcella
    Melis, Maurizio
    Cappellini, Sara
    Balestrieri, Cinzia
    Serra, Giancarlo
    Conti, Maria
    Zolfino, Teresa
    Casale, Michele
    Casu, Stefania
    Pasetto, Maria Cristina
    Barca, Lucia
    Salustro, Claudia
    Matta, Laura
    Scioscia, Rosetta
    Zamboni, Fausto
    Faa, Gavino
    Orru, Sandro
    Carcassi, Carlo
    PLOS ONE, 2016, 11 (01):
  • [40] Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes
    K J Guinan
    R T Cunningham
    A Meenagh
    A Gonzalez
    M M Dring
    B W McGuinness
    D Middleton
    C M Gardiner
    Genes & Immunity, 2010, 11 : 467 - 478